Ping, Fan

Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials

He, L., Wang, J., Ping, F., Yang, N., Huang, J., Li, Y., Xu, L., Li, W., & Zhang, H. (2022) · JAMA Internal Medicine

Diabetes Treatment and ManagementGallbladder and Bile Duct Disorders

Cited by 356

Vildagliptin increases butyrate-producing bacteria in the gut of diabetic rats

Zhang, Q., Xiao, X., Li, M., Yu, M., Ping, F., Zheng, J., Wang, T., & Wang, X. (2017) · PLOS ONE

Gut microbiota and healthOral microbiology and periodontitis research

Cited by 124

Featured article: Structure moderation of gut microbiota in liraglutide-treated diabetic male rats

Zhang, Q., Xiao, X., Zheng, J., Li, M., Yu, M., Ping, F., Wang, T., & Wang, X. (2018) · Experimental Biology and Medicine

Gut microbiota and healthOral microbiology and periodontitis research

Cited by 101

Liraglutide Inhibits Osteoclastogenesis and Improves Bone Loss by Downregulating Trem2 in Female Type 1 Diabetic Mice: Findings From Transcriptomics

Yu, J., Shi, Y.-C., Ping, F., Li, W., Zhang, H.-B., He, S.-L., Zhao, Y., Xu, L.-L., & Li, Y.-X. (2021) · Frontiers in Endocrinology

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 27

Impact of a dual glucose‐dependent insulinotropic peptide/ glucagon‐like peptide ‐1 receptor agonist tirzepatide on heart rate among patients with type 2 diabetes: A systematic review and pairwise and network meta‐analysis

Yang, Y., He, L., Liu, P., Wang, J., Yang, N., Li, Z., Ping, F., Xu, L., Li, W., Zhang, H., et al. (2024) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 12